Lanxess: UBS downgrades to 'neutral'

(CercleFinance.com) - UBS has downgraded its "buy" rating on the Lanxess stock to "neutral" and has cut its target price from 78 euros to 53 euros, which suggests upside potential of 8% for the share of the German specialty chemist.


"Resilience to a cyclical downturn could be tested in the coming quarters as various parts of the portfolio remain vulnerable," the broker warns in the summary of its research note.

Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.